Steve Melvyn Howdle
Chairman at The University of Nottingham
Profile
Steve Melvyn Howdle was the founder of Critical Pharmaceuticals Ltd., which was founded in 2002, where he held the title of Chief Scientific Officer.
Currently, he holds the position of Chairman at The University of Nottingham.
Steve Melvyn Howdle active positions
| Companies | Position | Start |
|---|---|---|
| The University of Nottingham | Chairman | - |
Former positions of Steve Melvyn Howdle
| Companies | Position | End |
|---|---|---|
Critical Pharmaceuticals Ltd.
 Critical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Critical Pharmaceuticals Ltd. operates as a clinical stage biotechnology company with interest in developing and producing biological drug products. The company product pipeline includes CP024: Nasal hGH, CP046: Nasal PTH, CP016: hGH Depot and CP018: Risperidone. Critical Pharmaceuticals was founded by Steve Howdle and Kevin Morris Shakesheff in 2002 and is headquartered in Nottingham, the United Kingdom. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Critical Pharmaceuticals Ltd.
Critical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Critical Pharmaceuticals Ltd. operates as a clinical stage biotechnology company with interest in developing and producing biological drug products. The company product pipeline includes CP024: Nasal hGH, CP046: Nasal PTH, CP016: hGH Depot and CP018: Risperidone. Critical Pharmaceuticals was founded by Steve Howdle and Kevin Morris Shakesheff in 2002 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Steve Melvyn Howdle